English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 糖尿病 > 欧州における糖尿病治療薬のデリバリー:市場および技術
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

欧州における糖尿病治療薬のデリバリー:市場および技術

Diabetes Drug Delivery Methods--Market and Technologies

発行 Frost & Sullivan
出版日 2006年06月 商品コード 41942
ページ情報 英文 193 pages
価格
詳細については [お問い合わせ] ボタンよりお問い合わせ下さい。

原文目次

Abstract

This Frost & Sullivan research service titled Drug Delivery for Diabetes-Market and Technologies provides an overview of advancements in drug delivery technologies in diabetes. It also provides a description of the revenues generated by present insulin delivery methods along with a complete analysis of key market drivers, restraints and trends prevailing in the European market.

Table of Contents

1 EXECUTIVE SUMMARY

  • Executive Summary of the Diabetes Drug Delivery Methods-Market and Technologies.
    • Market Overview

2 INTRODUCTION

  • Research Methodology
    • Research Methodology for the Diabetes Drug Delivery Methods- Market and Technologies
  • Exchange Rates
    • Currency Conversion
  • History Of Insulin
    • History

3 OVERVIEW OF INSULIN

  • Insulins
    • Animal Insulins
    • Semi-synthetic and Genetically Engineered Insulins

4 INSULIN DELIVERY

  • Current Delivery Devices - Technology
    • Insulin Syringes
    • Insulin Jet Injectors
    • Insulin Pumps
    • Insulin Pens
  • Current Delivery Devices - Market Engineering Research
    • Market Overview
    • Market Engineering Measurements
    • Market Drivers for Insulin Syringes Market
    • Market Restraints for Insulin Syringes Market
    • Market Drivers for Insulin Pumps and Jet Injectors Market
    • Market Restraints for Insulin Pumps and Jet Injectors Market
    • Market Drivers for Insulin Pens Market
    • Market Restraints for Insulin Pens Market
    • Competitive Structure
    • Market Share Analysis
    • Revenue Forecasts

5 NOVEL INSULIN DELIVERY DEVICES

  • Introduction
    • Advancements in Diabetes Therapy
  • Drug Delivery - Future Technologies
    • Inhaled Insulin
    • Oral Insulin
    • Transdermal Insulin
    • Nanotechnology
    • Diabetes Vaccine
    • Gene Therapy

6 MARKET ENGINEERING RESEARCH FOR INHALED INSULINS

  • Industry Challenges
    • Strategic Factors
  • Europe
    • Market Overview
    • Market Engineering Measurements
    • Market Drivers
    • Market Restraints
    • Competitive Structure
    • Revenue Forecasts
  • The United Kingdom
    • Market Overview
    • Market Engineering Measurements
    • Market Drivers
    • Market Restraints
    • Revenue Forecasts
  • Germany
    • Market Overview
    • Market Engineering Measurements
    • Market Drivers
    • Market Restraints
    • Revenue Forecasts
  • France
    • Market Overview
    • Market Engineering Measurements
    • Market Drivers
    • Market Restraints
    • Revenue Forecasts
  • Spain
    • Market Overview
    • Market Engineering Measurements
    • Market Drivers
    • Market Restraints
    • Revenue Forecasts
  • Italy
    • Market Overview
    • Market Engineering Measurements
    • Market Drivers
    • Market Restraints
    • Revenue Forecasts
  • Scandinavia
    • Market Overview
    • Market Engineering Measurements
    • Market Drivers
    • Market Restraints
    • Revenue Forecasts
  • Benelux
    • Market Overview
    • Market Engineering Measurements
    • Market Drivers
    • Market Restraints
    • Revenue Forecasts

7 STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN INHALED INSULIN MARKET

  • Market Engineering Strategic Recommendations
    • Market Engineering Strategy

8 FROST & SULLIVAN AWARDS

  • 2006 Frost & Sullivan Awards
    • Frost & Sullivan Awards for the European Diabetes Drug Delivery Market
    • Technology Innovation Award
    • Product Line Strategy Award
    • Market Leadership Award

9 DATABASE OF KEY INDUSTRY PARTICIPANTS

  • Key Industry Participants
    • Major Participants

10 APPENDIX

  • Decision Support Database
    • Diabetes Incidence
    • Diabetes Prevalence
    • Diabetes Prevalence Percent
    • Obesity Prevalence
    • Total Healthcare Expenditure
Back to Top